Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H14O4 |
Molecular Weight | 246.2586 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C)(OC(=O)C1=C(C=CC=C1)C(O)=O)C#C
InChI
InChIKey=CZGIRAWWWHPJHM-UHFFFAOYSA-N
InChI=1S/C14H14O4/c1-4-14(3,5-2)18-13(17)11-9-7-6-8-10(11)12(15)16/h1,6-9H,5H2,2-3H3,(H,15,16)
Molecular Formula | C14H14O4 |
Molecular Weight | 246.2586 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Phthalofyne (3-methyl-1-pentyn-3-yl acid phthalate) is a synthetic chemical compound demonstrated to have trichuricidal activity against both Trichuris vulpis and Trichuris trichiura. It was used in veterinary medicine against dog whipworm, Trichuris vulpis, under the brand name Whipcide.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Trichuris vulpis Sources: https://www.ncbi.nlm.nih.gov/pubmed/13252554 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Whipcide Approved UsePhthalofyne is used for the treatment of whipworm (Trichuris vulpis) infection in dogs. Launch Date1954 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13508999
Phthalofyne was given to 10 healthy young Filipino males harboring Trichuris trichiura. Of 7 cases who received 100 to 125 mg./kg. by mouth, alone or in combination with the same dose given by enema, 4 had rather minimal complaints of nausea and/or vomiting and none received significant therapeutic benefit. The highest oral dose, 175 mg./kg. given to a single patient, produced considerable nausea and apparently complete regurgitation of gastric contents and no therapeutic benefit, suggesting that effective single oral doses would not be easily retained. The phthalofyne enemas, containing respectively 200 mg./kg. and 450 mg./kg. of the drug, and given one week apart to a single patient, produced no side effects and no significant therapeutic effect.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:16:15 GMT 2023
by
admin
on
Fri Dec 15 15:16:15 GMT 2023
|
Record UNII |
TA9XO4D05J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB07819MIG
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY | |||
|
25614
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY | |||
|
100000080449
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY | |||
|
2277
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107106
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY | |||
|
C75230
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY | |||
|
8573
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY | |||
|
TA9XO4D05J
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY | |||
|
131-67-9
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY | |||
|
DB11449
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY | |||
|
m8756
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID9057634
Created by
admin on Fri Dec 15 15:16:15 GMT 2023 , Edited by admin on Fri Dec 15 15:16:15 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |